True Wealth Design’s CervoMed CRVO Stock Holding History

True Wealth Design’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5	Closed	-$32	–	2758
2025 Q2	$32	Buy	5 +1	+25%	+$9	﹤0.01%	2456
2025 Q1	$37	Buy	+4	New	+$15	﹤0.01%	2453

Other funds holding CRVO

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

True Wealth Design's CRVO Position: Q3 2025 in Review

True Wealth Design sold out of CervoMed (CRVO) in Q3 2025, closing a stake of 5 shares — an estimated $32 sold.

True Wealth Design first reported a position in CRVO in Q1 2025 and held it in 2 quarters. The position peaked at $37 in Q1 2025. 45 funds tracked by Wall St. Rank hold CRVO as of Q3 2025.

True Wealth Design reported no remaining CervoMed position as of Q3 2025 after selling out during the quarter.
True Wealth Design sold 5 CervoMed shares in Q3 2025, an estimated $32.
True Wealth Design first reported a position in CervoMed in Q1 2025 and held it in 2 quarters.
True Wealth Design's CervoMed position peaked at $37 in Q1 2025.
45 funds tracked by Wall St. Rank held CervoMed as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.